Innovator US Equity Power Buffer ETF May (PMAY) News

Short Squeeze coming ??

ATTENTION: There are other boards to discuss politics.

Josh Brown, CEO at Ritholtz Wealth Management
buys Rocket Companies.

https://www.cnbc.com/video/2025/04/04/josh-brown-buys-rocket-companies-and-buys-more-amazon-chevron-uber-and-sells-nasdaq.html

Eric Clapton - I Still Do

A belated Happy Birthday from me!

https://youtu.be/cZQ4-hWSFZk

The entire over-priced market took a big dump this week. Don't listen to these left-wing-nitwits who try to pin it on Trump. The criminal funding and fake market is drying up - It's about time. Halberd will have it's day after this all settles out.

Fan your money, so invest as you see fit. 
I have been winning for years and am looking forward to the year IDCC reaches a billion in revenue.

sun, fully understand, and thanks for explaining, but there could always be a higher bid changing the terms completely. This is NOT at all unusual with companies taking over others, especially the more successful the more likely another bid arises.

...

Interesting… an executive at Commonwealth Bank of Australia has been ‘liking’/‘celebrating’ ModuLink’s updates on their modular home on LinkedIn. Not sure if they’re just interested in ModuLink Australia (or they’re a friend) or if there is a pertinent business connection here (ie partner, investor

Is Brian Foote still a Director of Humbl Inc. and thus subject to the Rule 144 selling restrictions for “Officers/Directors”?

He is no longer showing as one on OTC Markets despite the market being told the following:
Thiago Moura, Chairman and CEO of Ybyra, will assume the role

BNAI, new 52 week low
https://investorshub.advfn.com/uimage/uploads/2025/4/5/ykfooIMG_5890.gif

Misleading is still spinning the data. It's been three years since the trial was completed, and there’s still no clear information. He needs to stop cherry-picking data and follow industry standards instead of pushing his own theories.

Mr. Cooper Group’s Chairman and CEO Jay Bray will become President and CEO of Rocket Mortgage, reporting to Krishna.

Varun Krishna is the Chief Executive Officer of Rocket Companies.

So....

Now I want to pose a ?, has anyone ever seen where the acquired

Immunocleansing-Associated Toxicity Syndrome (ICATS) in CAR T-cell treated patients with autoimmune disease

Altered gut microbiota composition in autoimmune disease patients undergoing CD19-CAR T-cell therapy

Bosai and hosai state thevsame negative message with 2 different ids maybe that is kund with 2 other ids. These people dont grt it. Anavex has the goods.

Everyone make sure you give credit to Karmakazi, aka ThreeEmInEn, because he will cry if you don't give him credit for his useless "DD". This clown is the most I secure idiot on these boards. LMFAO.

lj: NVDA call
Never expected to get that low. Do I want to take $30K and buy back the call, or do I want to spread the $30K around in beaten-down tech stocks, like NVDA itself or SMCI, e.g.
There is many factors to take into account.
Have a nice weekend. (I am weeding the gard

Schiff Exposes Republicans' Midnight Budget Scheme.

https://www.youtube.com/watch?v=vg_3Dtzamgo

CRSP, new 52 week low
https://investorshub.advfn.com/uimage/uploads/2025/4/5/rlwqvIMG_5889.gif

Humble, I can also post everything from HCWC to this board until you stop lying. I will challenge you to the end and I really think the end is almost here for both companies.

BIEL'S paid Carney Barker at it again....🤠

Additional Updates:

1. Market Problem: USA Today article re: Zelle shutting down its standalone fiat consumer payments app due to, per the U.S. CFPB, a reported $870 Million in consumer losses from fraud and scams on the platform: https://www.usatoday.com/story/money/2025/04/04/zelle

I'm still looking out for clock stop one news from Anavex perhaps in late Q3 or into Q4

Why so late? AVXL's response to the Day 120 List of Questions (expected 120 days after the December 23, 2024 MAA validation) could be anticipated around mid-year 2025.

There will be green days and red days to get that penny

OVER 9 YEARS !
"...there are currently 74 participants receiving blarcamesine within the Compassionate Use Program, who continued treatment with blarcamesine subsequent completion of respective preceding open-label-extension studies from both ANAVEX®2-73-AD-EP-004 in early AD and fr

The judges must be working with the shorts too since they keep ruling against Cyberlux.

I love the delusions of the pump squad